Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study
Laurence K. Albiges, Brian I. Rini, Katriina Johanna Peltola, G.A. De Velasco Oria, Mauricio Burotto, Cristina Suárez and 14 more
- Rank
- 71 of 3,639
- Percentile
- top 2%
- Where
- Annals of Oncology, 2023
- Citations
- 53
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.